XML 37 R25.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2020
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

Three Months Ended March 31, 

Nine Months Ended March 31, 

    

2019

    

2020

    

2019

    

2020

Cost of goods sold

$

182

$

189

$

539

$

517

Selling, general and administrative

5,543

5,520

 

18,487

 

17,153

Research and development

163

129

 

488

 

427

Stock-based compensation expense

$

5,888

$

5,838

$

19,514

$

18,097

Summary of stock option activity

Weighted Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2019

 

515,884

$

33.74

Granted

 

13,263

101.31

Exercised

 

(201,003)

20.45

Expired or forfeited

 

(1,092)

85.37

Outstanding at March 31, 2020

 

327,052

44.47

 

2.7 years

$

8,867

Exercisable at March 31, 2020

 

295,525

39.85

 

2.0 years

8,867

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2019

 

521,140

$

73.97

Granted

 

300,998

88.26

Vested

 

(388,756)

68.60

Forfeited

 

(13,907)

83.24

Nonvested at March 31, 2020

 

419,475

88.89